Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03843424 · ClinicalTrials.gov registry record · NA
Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 1,460
- Enrollment target
NCT03843424: Completed NA study, sponsored by Washington University School of Medicine.
NCT03843424 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 1,460 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03843424, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,460 participants
- Enrollment target
Study Summary
The US Preventive Services Task Force (USPSTF) recommends that providers screen children aged 6 years and older for obesity and offer or refer them to a comprehensive behavioral intervention (≥26 hours over a period of up to 12 months) to promote improvement in weight status. Family-based behavioral treatment (FBT) is an effective treatment that targets both child and parents and meets the USPSTF recommendations. By contrast, the American Medical Association (AMA) recommends a staged approach to childhood obesity screening and counseling, which begins with prevention counseling by the primary care provider (PCP) and includes assessment of weight status, patient/family motivation and readiness to change, promotion of healthy eating and activity habits, and use of health behavior change strategies. Our study compares a staged approach enhanced standard of care (eSOC) vs. eSOC + FBT, to provide families and PCPs with information on the best intervention approach for the behavioral treatment of childhood obesity. Our project seeks to fill the gap in the evidence on family-based weight management in primary care settings among diverse and underserved populations with a special focus on Black children, families insured by Medicaid, and sex differences.
Interventions
- BEHAVIORAL eSOC program
- BEHAVIORAL FBT program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,460 participants |
| Start Date | 2019-09-12 |
| Est. Completion | 2024-07-26 |
| Phase | NA |
What the finished NCT03843424 record still lists
NCT03843424 is an interventional study that assigns participants to a tested intervention. Its 1,460 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which eSOC program is the first listed.
NCT03843424 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03843424 about?
NCT03843424 is a clinical study titled "Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers". The US Preventive Services Task Force (USPSTF) recommends that providers screen children aged 6 years and older for obesity and offer or refer them to a comprehensive behavioral intervention (≥26 hours over a period of up to 12 months) to promote improvement in weight status. Family-based behavioral...
What is the current status of trial NCT03843424?
This trial is currently completed. It is a NA study. The enrollment target is 1,460 participants. The study started on 2019-09-12. Estimated completion is 2024-07-26.
What interventions are being tested in trial NCT03843424?
The interventions under investigation include: eSOC program (BEHAVIORAL), FBT program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03843424?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03843424's enrollment target sits among peer trials
1,460 68th of 2000 higher than 1,933 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03936361 · 1,456 participants · Phase 3
Statins In Intracerbral Hemorrhage
- NCT06782347 · 1,454 participants · NA
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- NCT05229341 · 1,450 participants · NA
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI